摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-methyl-6,7-dihydropyrrolo[2,3-c]-azepine-4,8(1H,5H)-dione | 137003-97-5

中文名称
——
中文别名
——
英文名称
7-methyl-6,7-dihydropyrrolo[2,3-c]-azepine-4,8(1H,5H)-dione
英文别名
7-methyl-1,4,5,6,7,8-hexahydropyrrolo<2,3-c>azepine-4,8-dione;7-methyl-6,7-dihydro-1H,5H-pyrrolo<2,3-c>azepine-4,8-dione;7-methyl-6,7-dihydropyrrolo<2,3-c>azepine-4,8(1H,5H)-dione;7-methyl-6,7-dihydropyrrolo[2,3-c]azepine-4,8(1H,5H)-dione;Pyrrolo[2,3-c]azepine-4,8(1H,5H)-dione, 6,7-dihydro-7-methyl-;7-methyl-5,6-dihydro-1H-pyrrolo[2,3-c]azepine-4,8-dione
7-methyl-6,7-dihydropyrrolo[2,3-c]-azepine-4,8(1H,5H)-dione化学式
CAS
137003-97-5
化学式
C9H10N2O2
mdl
——
分子量
178.191
InChiKey
GVLAPXCEGZFQBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    53.2
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:668576f486363763730addc989d442c0
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and Pharmacological Evaluation of Pyrroloazepine Derivatives as Potent Antihypertensive Agents with Antiplatelet Aggregation Activity.
    摘要:
    合成了一系列1-氨基烷基吡咯并[2, 3-c]氮杂环辛酮衍生物,并评估其作为α1肾上腺素能和血清素2(5-HT2)受体拮抗剂的活性,旨在寻找一种新型的具有强效双重活性的抗高血压药物。部分在1位具有4-[4-(4-氟苯甲酰基)piperidino]丁基基团的化合物显示了双重活性,并在吡咯氮杂环的4位取代基方面表现出显著差异。在本研究中获得的化合物中,(E)-1-[4-[4-(4-氟苯甲酰基)piperidino]丁基]-4-羟基亚胺-7-甲基-1, 4, 5, 6, 7, 8-六氢吡咯并[2, 3-c]氮杂环辛酮(15a,SUN9221)在离体豚鼠动脉中表现出强效的α1-肾上腺素能拮抗活性(pA2=8.89±0.21)和5-HT2拮抗活性(pA2=8.74±0.22)。这一化合物表现出抗高血压活性,其作用持续时间相当于口服给药的哌唑嗪或多沙唑嗪(3 mg/kg)在清醒自发性高血压大鼠中的效果,同时还具有强效的抗血小板聚集活性。
    DOI:
    10.1248/cpb.47.246
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Pharmacological Evaluation of Pyrroloazepine Derivatives as Potent Antihypertensive Agents with Antiplatelet Aggregation Activity.
    摘要:
    合成了一系列1-氨基烷基吡咯并[2, 3-c]氮杂环辛酮衍生物,并评估其作为α1肾上腺素能和血清素2(5-HT2)受体拮抗剂的活性,旨在寻找一种新型的具有强效双重活性的抗高血压药物。部分在1位具有4-[4-(4-氟苯甲酰基)piperidino]丁基基团的化合物显示了双重活性,并在吡咯氮杂环的4位取代基方面表现出显著差异。在本研究中获得的化合物中,(E)-1-[4-[4-(4-氟苯甲酰基)piperidino]丁基]-4-羟基亚胺-7-甲基-1, 4, 5, 6, 7, 8-六氢吡咯并[2, 3-c]氮杂环辛酮(15a,SUN9221)在离体豚鼠动脉中表现出强效的α1-肾上腺素能拮抗活性(pA2=8.89±0.21)和5-HT2拮抗活性(pA2=8.74±0.22)。这一化合物表现出抗高血压活性,其作用持续时间相当于口服给药的哌唑嗪或多沙唑嗪(3 mg/kg)在清醒自发性高血压大鼠中的效果,同时还具有强效的抗血小板聚集活性。
    DOI:
    10.1248/cpb.47.246
点击查看最新优质反应信息

文献信息

  • Synthesis of pyrroloazepines. Facile synthesis of 2-substituted pyrrole derivatives by the phosgene method
    作者:Hidetsura Cho、Shinsuke Matsuki、Akira Mizuno、Hirokazu Annoura、Toshio Tatsuoka
    DOI:10.1002/jhet.5570340115
    日期:1997.1
    A highly convenient method for the synthesis of 2-substituted pyrrole derivatives 7a-c from pyrrole using phosgene was developed. Successively, 7-methyl-6,7-dihydro-1H,5H-pyrrolo[2,3-c]azepine-4,8-dione 1a and 6,7-dihydro-1H,5H-pyrrolo[2,3-c]azepine-4,8-dione 1b (aldisin) were synthesized by phosphorus pentoxide/methanesulfonate and polyphosphoric acid cyclization.
    开发了一种使用光气从吡咯合成2-取代的吡咯衍生物7a-c的非常方便的方法。依次为7-甲基-6,7-二氢-1 H,5 H-吡咯并[2,3 - c ]氮杂-4,8-​​二酮1a和6,7-二氢-1 H,5 H-吡咯并[2 ,3- ç ]氮杂卓-4,8-二酮1B(aldisin)通过五氧化二磷/甲磺酸和多磷酸环化合成。
  • Pyrroloazepine derivatives
    申请人:Suntory Limited
    公开号:US05206239A1
    公开(公告)日:1993-04-27
    Disclosed herein are pyrroloazepine derivatives, which are useful as therapeutics for circulatory diseases, represented by the following formula (I): ##STR1## wherein R means a hydrogen atom, a linear or branched C.sub.1-6 alkyl group or a C.sub.7-10 aralkyl group, A denotes a linear or branched C.sub.2-10 alkylene, alkenylene or alkynylene group, Z stands for O, NOR.sub.1 or NOCOR.sub.5 in which R.sub.1 and R.sub.5 is a hydrogen atom or an alkyl, aryl or aralkyl group, and Y means a particular piperidinyl or pyrrolidinyl group; and salts thereof. Their preparation processes are also disclosed.
    本文披露了一种吡咯环庚烯衍生物,可用作治疗循环系统疾病的药物,其化学式如下(I):其中R代表氢原子、直链或支链C.sub.1-6烷基或C.sub.7-10芳基烷基,A代表直链或支链C.sub.2-10烷基、烯烃基或炔烃基,Z代表O、NOR.sub.1或NOCOR.sub.5,其中R.sub.1和R.sub.5为氢原子或烷基、芳基或芳基烷基,Y代表特定的哌啶基或吡咯基;以及其盐。同时也披露了它们的制备过程。
  • Ring Construction of Several Heterocycles with Phosphorus Pentoxide-Methanesulfonic Acid (PPMA)
    作者:Hidetsura Cho、Shinsuke Matsuki
    DOI:10.3987/com-95-7238
    日期:——
    The cyclization reactions with CH3SO3H/P2O5 (PPMA) or CF3SO3H/P2O5 (PPTMA) at 80-100 degrees C for 3-10 min afforded several heterocycles (6,7-dihydropyrrolo[2,3-(c) under bar]azepin-4,8(1 (H) under bar, 5 (H) under bar)-dione, 4-oxo-4,5,6,7-tetrahydrothianaphthene, carbostyril derivatives).
  • Chem. Pharm. Bull. 1999, 47, 246-256
    作者:
    DOI:——
    日期:——
  • EP0551527A1
    申请人:——
    公开号:EP0551527A1
    公开(公告)日:1993-07-21
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate